Lexicon Pharmaceuticals Revenue
Pharmaceutical Manufacturing • 
The Woodlands, Texas, United States • 201-500 Employees
Lexicon Pharmaceuticals revenue & valuation
| Annual revenue | $58,500,000 |
| Revenue per employee | $192,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $187,000,000 |
| Total funding | $322,200,000 |
Key Contacts at Lexicon Pharmaceuticals
Diane Sullivan
Member, Board Of Directors
Michael Pocza
Eastern U.S. Sales Director
Paul Chen
Senior Director, Trade And Channel Management
Balaji V. Kadri
Senior Director Of Pharmaceutics & Clinical Supplies
Ivan Cheung
Member Of Board Of Directors
Kartik Patel
Associate Director, Drug Safety Operations
Thomas J. Noto
Senior Director Regulatory Operations
Thomas Diezi
Associate Director, Drug Product Manufacturing
Alina Cocuzza
Executive Director And Head, External Affairs
Megan Lund
Senior Director Market Insights
Company overview
| Headquarters | 8800 Technology Forest, The Woodlands, TX 77381, US |
| Phone number | +12818633000 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Pharmaceutical, Innovation, Disease, Biopharma, Knockout, Novel Drug |
| Founded | 1995 |
| Employees | 201-500 |
| Socials |
Lexicon Pharmaceuticals Email Formats
Lexicon Pharmaceuticals uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@lexpharma.com), used 47% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@lexpharma.com | 47% |
{first name}{last name} | johndoe@lexpharma.com | 47% |
{last name}{last name} | doedoe@lexpharma.com | 3.5% |
About Lexicon Pharmaceuticals
Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. The Genome: Our Source of Discovery We have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. We have integrated a series of recombinant DNA and chemistry technologies into a systematic drug discovery and development process. Our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. A Diverse Pipeline of Targeted Therapies Our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indications with high unmet medical need. All of our drug candidates are new molecular entities discovered internally by our dedicated drug discovery teams and designed to affect particular points on a genetically-defined pathway that can be used to fight a disease process. We have advanced new therapies across a wide spectrum of human disease, from conditions affecting millions of people, such as diabetes, to carcinoid syndrome, an orphan cancer indication with few treatment options.
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Lexicon Pharmaceuticals has 145 employees across 14 departments.
Departments
Number of employees
Funding Data
Explore Lexicon Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.
Lexicon Pharmaceuticals Tech Stack
Discover the technologies and tools that power Lexicon Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
SSL/TLS certificate authorities
Development
CDN
Security
PaaS
CRM
Tag managers
Hosting
Webmail
CDN
JavaScript frameworks
Miscellaneous
Latvia
Frequently asked questions
4.8
40,000 users
